紫杉醇或草酸铂联合氟脲嘧啶/亚叶酸治疗晚期胃癌的对比研究

白桦, 申维玺, 李先明, 陈亦欣, 郑瑾, 叶建增, 徐敏, 许瑞莲

白桦, 申维玺, 李先明, 陈亦欣, 郑瑾, 叶建增, 徐敏, 许瑞莲. 紫杉醇或草酸铂联合氟脲嘧啶/亚叶酸治疗晚期胃癌的对比研究[J]. 中国肿瘤临床, 2007, 34(18): 1039-1040.
引用本文: 白桦, 申维玺, 李先明, 陈亦欣, 郑瑾, 叶建增, 徐敏, 许瑞莲. 紫杉醇或草酸铂联合氟脲嘧啶/亚叶酸治疗晚期胃癌的对比研究[J]. 中国肿瘤临床, 2007, 34(18): 1039-1040.
Bai Hua, Shen Weixi, Li Xianming, Chen Yihuan, Zheng Jin, Ye Jianzeng, Xu Min, Xu Ruilian. Comparison between the Effects of Paclitaxel and Oxaliplatin Combined with 5-Fluorouracil/Folinic Acid in the Treatment of Advanced Gastric Cancer[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2007, 34(18): 1039-1040.
Citation: Bai Hua, Shen Weixi, Li Xianming, Chen Yihuan, Zheng Jin, Ye Jianzeng, Xu Min, Xu Ruilian. Comparison between the Effects of Paclitaxel and Oxaliplatin Combined with 5-Fluorouracil/Folinic Acid in the Treatment of Advanced Gastric Cancer[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2007, 34(18): 1039-1040.

紫杉醇或草酸铂联合氟脲嘧啶/亚叶酸治疗晚期胃癌的对比研究

详细信息
    通讯作者:

    白桦

Comparison between the Effects of Paclitaxel and Oxaliplatin Combined with 5-Fluorouracil/Folinic Acid in the Treatment of Advanced Gastric Cancer

  • 摘要: 目的 :观察并比较紫杉醇联合氟脲嘧啶/亚叶酸(5-FU/CF)与草酸铂联合5-FU/CF治疗晚期胃癌的疗效及毒副反应。 方法 :随机将晚期胃癌患者分为两组:紫杉醇联合5-FU/CF组(A组)27例,草酸铂联合5-FU/CF(B组)29例。每例患者至少完成2周期以上的化疗。 结果 :A组有效率(CR+PR)为59.26%,中位缓解期5.8个月,中位生存期11.6个月。B组有效率(CR+PR)为55.17%,中位缓解期6.2个月,中位生存期10.8个月。两组的主要毒副反应为骨髓抑制、神经毒性和消化道反应。两者相比A组的骨髓抑制、脱发较重,B组轻度腹泻的发生率稍高。 结论 :紫杉醇联合5-FU/CF与草酸铂联合5-FU/CF两方案治疗晚期胃癌疗效相当,毒副反应均可耐受。
    Abstract: Objective :To observe and compare the therapeutic efficacy and adverse side effects ofpaclitaxel and oxaliplatin (L-OHP) combined with 5-fluorouracil/leucovorin (5-FU/CF) in the treatmentof patients with advanced gastric cancer (AGC). Methods :A total of 56 patients with AGC were ran-domized into two groups. Two or more cycles of chemotherapy were completed. Group A consisted of 27patients who received paclitaxel plus 5-FU/CF and group B consisted of 29 patients who received ox-aliplatin plus 5-FU/CF. Results :In group A and B, the response rate (CR +PR) was 59.26% and55.17%, the median duration of the therapeutic effects was 5.8 and 6.2 months, and the median sur-vival of patients was 11.6 and 10.8 months, respectively. The most common side effects in both groupswere myelosuppression, mild neuro-sensory toxicity and sensitivity of the gastrointestinal tract. Com-pared with patients in group A, patients in group B experienced milder myelosuppression and more se-rious diarrhea. Conclusion :The effects of paclitaxel or L-OHP combined with 5-FU/CF are compara-ble. The adverse side effects are mild and patients tolerate the chemotherapy well.
  • [1] 周继昌.实用肿瘤内科学[M].第2版.北京:人民卫生出版社,2003.28-30
    [2] 金懋林.抗癌药物治疗胃癌进展.见:胥彬,许建华.著译.抗癌药物与肿瘤化学治疗进展 [M].北京:科学出版社,2001.55-64
    [3] 林万隆,陈强.奥沙利铂的药理作用及临床应用[J].中国肿瘤临床,2000,27(11):872-874
    [4] 金懋林.化学治疗的发展与运用. 奥沙利铂联合 LV5FU 治疗晚期或转移性胃癌的多中心研究[J].中华肿瘤杂志,2003,25(2):172-174
    [5] 官成浓,蔡文斌,等.FOLFOX方案治疗晚期胃癌55例疗效观察[J].中国肿瘤临床,2006,33(3):171-172
    [6] 何艳玲,申东兰,彭安.草酸铂联合氟尿嘧啶和亚叶酸钙治疗晚期胃癌[J].肿瘤防治研究,2006,33(2):108-109
    [7] Murad AM,Petroianu A,Guimaraes RC,et al.Phase Ⅱ trial ofthe combination of pacilitaxel and 5-fluorouracil in the treatmentof advanced gastric cancer:a novel,safe,and effective regimen[J].Am J Clin Oncol,1999,22(6):580-586
    [8] 周宁宁,周中梅,刘茂珍,等.紫杉醇和5-氟尿嘧啶 / 醛氢叶酸双周疗法治疗晚期胃癌的初步报告[J].癌症,2003,22(8):867-869
    [9] 冯继锋,陆建伟,孙小峰,等.氟尿嘧啶 / 亚叶酸钙 + 紫杉醇联合化疗双周方案治疗晚期胃癌[J].癌症,2004,23(12):1704-1706
    [10] 王晓红,白淑平,赵玲.PLF方案治疗42例晚期胃癌疗效观察[J].实用肿瘤学杂志,2006,20(1):34-35
计量
  • 文章访问数:  1
  • HTML全文浏览量:  0
  • PDF下载量:  1
  • 被引次数: 0
出版历程
  • 收稿日期:  2007-02-01
  • 修回日期:  2007-04-05
  • 发布日期:  2007-09-29

目录

    /

    返回文章
    返回